Schwannoma of jugular foramen

Summary

Schwannoma of jugular foramen (MONDO:0003980) is a disease. A subtype of peripheral nerve schwannoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	schwannoma of jugular foramen
Mondo ID	MONDO:0003980
DOID	DOID:6735
NCIT	C5323
UMLS	C1334300
MedGen	272780
GARD	0023760
Anatomy (UBERON)	UBERON:0005456
Is cancer (heuristic)	no

Also known as: jugular Foramen neurilemmoma · jugular foramen schwannoma · neurilemmoma of jugular Foramen · neurilemmoma of the jugular Foramen · schwannoma of the jugular Foramen

Disease family

This is a subtype of peripheral nerve schwannoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral nervous system neoplasm › nerve sheath neoplasm › schwannoma › peripheral nerve schwannoma › schwannoma of jugular foramen

Related subtypes (3): schwannoma of ureter, neurilemmoma of the pleura, mediastinal schwannoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.